Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...
The prolonged U.S. government shutdown is putting millions of Americans at risk of missing their November food stamp benefits, a vital lifeline for low-income households. The U.S. Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback